These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
196 related items for PubMed ID: 6210137
1. Calcium channel activation in vascular smooth muscle by BAY K 8644. Su CM, Swamy VC, Triggle DJ. Can J Physiol Pharmacol; 1984 Nov; 62(11):1401-10. PubMed ID: 6210137 [Abstract] [Full Text] [Related]
2. Ca2+ channel ligand sensitive responses to the phorbol ester 12-O-tetradecanoylphorbol 13-acetate in vascular smooth muscle. Wei XY, Triggle DJ. Can J Physiol Pharmacol; 1986 Dec; 64(12):1489-96. PubMed ID: 2435389 [Abstract] [Full Text] [Related]
3. Effects of Bay K 8644 and nifedipine on femoral arteries of spontaneously hypertensive rats. Aoki K, Asano M. Br J Pharmacol; 1986 May; 88(1):221-30. PubMed ID: 2423174 [Abstract] [Full Text] [Related]
4. The effect of the calcium channel agonist, Bay K-8644 on human vascular smooth muscle. Gopalakrishnan V, Park LE, Triggle CR. Eur J Pharmacol; 1985 Jul 31; 113(3):447-51. PubMed ID: 2412849 [Abstract] [Full Text] [Related]
9. Contractile effects of Bay k 8644, a dihydropyridine calcium agonist, on isolated femoral arteries from spontaneously hypertensive rats. Asano M, Aoki K, Matsuda T. J Pharmacol Exp Ther; 1986 Oct 31; 239(1):198-205. PubMed ID: 2428972 [Abstract] [Full Text] [Related]
10. Differential antagonism by Bay k 8644, a dihydropyridine calcium agonist, of the negative inotropic effects of nifedipine, verapamil, diltiazem and manganese ions in canine ventricular muscle. Ishii K, Taira N, Yanagisawa T. Br J Pharmacol; 1985 Feb 31; 84(2):577-84. PubMed ID: 2579702 [Abstract] [Full Text] [Related]
11. A novel 1,4 dihydropyridine, BAY K 8644, with contractile effects on vascular smooth muscle. Mikkelsen E, Nyborg NC, Kazda S. Acta Pharmacol Toxicol (Copenh); 1985 Jan 31; 56(1):44-9. PubMed ID: 2579520 [Abstract] [Full Text] [Related]
13. Calcium agonism, a new mechanism for positive inotropy. Hemodynamic effects and mode of action of BAY K 8644. Schramm M, Towart R, Kazda S, Thomas G, Franckowiak G. Adv Myocardiol; 1985 Jan 31; 6():59-70. PubMed ID: 2581301 [Abstract] [Full Text] [Related]
15. In vitro comparative studies of the calcium-entry activators YC-170, CGP 28392, and BAY K 8644. Rogg H, Criscione L, Truog A, Meier M. J Cardiovasc Pharmacol; 1985 Jan 31; 7 Suppl 6():S31-7. PubMed ID: 2414592 [Abstract] [Full Text] [Related]
19. L-type Ca2+ channels activation and contraction elicited by myricetin on vascular smooth muscles. Fusi F, Saponara S, Frosini M, Gorelli B, Sgaragli G. Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec 31; 368(6):470-8. PubMed ID: 14618297 [Abstract] [Full Text] [Related]
20. BAY K 8644 potentiates and A23187 inhibits hypoxic vasoconstriction in rat lungs. McMurtry IF. Am J Physiol; 1985 Oct 31; 249(4 Pt 2):H741-6. PubMed ID: 2413777 [Abstract] [Full Text] [Related] Page: [Next] [New Search]